Integra Lifesciences Holdings Corp (IART)

Cost of Revenue

$787.58M

TTM · Period ending: Sep 30, 2026 · USD

IART Cost of Revenue

Latest reported$787.58Mperiod endingSep 30, 2026

IART TTM Cost of Revenue ($1.90M → $787.58M)

TTM cost of revenue

High-resolution chart · PNG

IART cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Integra Lifesciences Holdings Corp Cost of Revenue — Trailing twelve months (TTM) (USD)
Period ending	Cost of Revenue (USD)
Sep 30, 2026	787,577,000
Jun 30, 2026	762,215,000
Mar 31, 2026	769,471,000
Dec 31, 2025	790,011,000
Sep 30, 2025	764,022,000
Jun 30, 2025	768,664,000
Mar 31, 2025	754,649,000
Dec 31, 2024	728,466,000
Sep 30, 2024	705,438,000
Jun 30, 2024	688,918,000
Mar 31, 2024	670,901,000
Dec 31, 2023	656,838,000
Sep 30, 2023	634,229,000
Jun 30, 2023	618,598,000
Mar 31, 2023	592,761,000
Dec 31, 2022	587,355,000
Sep 30, 2022	595,668,000
Jun 30, 2022	591,691,000
Mar 31, 2022	594,554,000
Dec 31, 2021	597,808,000
Sep 30, 2021	588,627,000
Jun 30, 2021	578,970,000
Mar 31, 2021	533,181,000
Dec 31, 2020	520,834,000
Sep 30, 2020	523,227,000
Jun 30, 2020	531,052,000
Mar 31, 2020	569,245,000
Dec 31, 2019	564,681,000
Sep 30, 2019	561,683,000
Jun 30, 2019	562,292,000
Mar 31, 2019	556,186,000
Dec 31, 2018	571,496,000
Sep 30, 2018	573,203,000
Jun 30, 2018	531,715,000
Mar 31, 2018	493,148,000
Dec 31, 2017	435,511,000
Sep 30, 2017	372,762,000
Jun 30, 2017	360,334,000
Mar 31, 2017	350,901,000
Dec 31, 2016	349,089,000
Sep 30, 2016	353,668,000
Jun 30, 2016	350,408,000
Mar 31, 2016	347,382,000
Dec 31, 2015	349,331,000
Sep 30, 2015	356,798,000
Jun 30, 2015	356,703,000
Mar 31, 2015	357,140,000
Dec 31, 2014	352,801,000
Sep 30, 2014	341,981,000
Jun 30, 2014	340,108,000
Mar 31, 2014	336,200,000
Dec 31, 2013	334,085,000
Sep 30, 2013	329,367,000
Jun 30, 2013	324,814,000
Mar 31, 2013	320,020,000
Dec 31, 2012	314,427,000
Sep 30, 2012	315,237,000
Jun 30, 2012	314,340,000
Mar 31, 2012	308,904,000
Dec 31, 2011	299,150,000
Sep 30, 2011	287,716,000
Jun 30, 2011	278,259,000
Mar 31, 2011	269,885,000
Dec 31, 2010	268,188,000
Sep 30, 2010	260,826,000
Jun 30, 2010	254,653,000
Mar 31, 2010	249,994,000
Dec 31, 2009	244,918,000
Sep 30, 2009	249,112,000
Jun 30, 2009	250,408,000
Mar 31, 2009	248,762,000
Dec 31, 2008	252,826,000
Sep 30, 2008	247,114,000
Jun 30, 2008	233,660,000
Mar 31, 2008	228,309,000
Dec 31, 2007	214,674,000
Sep 30, 2007	203,693,000
Jun 30, 2007	200,389,000
Mar 31, 2007	188,954,000
Dec 31, 2006	168,314,000
Sep 30, 2006	145,121,000
Jun 30, 2006	123,575,000
Mar 31, 2006	109,341,000
Dec 31, 2005	105,537,000
Sep 30, 2005	100,506,000
Jun 30, 2005	96,905,000
Mar 31, 2005	91,431,000
Dec 31, 2004	87,299,000
Sep 30, 2004	85,012,000
Jun 30, 2004	81,470,000
Mar 31, 2004	76,895,000
Dec 31, 2003	70,597,000
Sep 30, 2003	63,831,000
Jun 30, 2003	57,572,000
Mar 31, 2003	49,947,000
Dec 31, 2002	45,772,000
Sep 30, 2002	41,561,000
Jun 30, 2002	38,103,000
Mar 31, 2002	36,948,000
Dec 31, 2001	34,583,000